comparemela.com

Latest Breaking News On - Controlled equity offering sales agreement - Page 1 : comparemela.com

Lineage Cell Therapeutics : Immediate Report -March 24, 2024 at 04:37 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT .

New yorkUnited statesCity of new yorkGeorgea samuelSubsidiary of the companyCommission file numberLineage cell therapeutics incExchange commission theGovernmental authorityB riley securities incCantor fitzgerald coCompany the prospectusExchange commissionWarranties of the companyPlacement shares of the companyCompany or lineage

EVOGENE : AND ITS SUBSIDIARIES INTERIM CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K -September 13, 2023 at 10:27 am EDT

EVOGENE LTD. AND ITS SUBSIDIARIES INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 .

United statesState of israelLavie bio ltdLavie bio tech incCanonic ltdEvofuel ltdLavie bio incAgro leads ltdTaxon biosciences incCompany in biomicaCorteva incEvogene incCompugen ltdCasterra ag ltdEvogene ltdCompany to biomica

Portage Biotech : NOTICE TO READER OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -Today at 05:30 pm

NOTICE TO READER OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS The condensed consolidated interim financial statements of Portage Biotech Inc. are comprised of the.

United statesBritish virgin islandsLincoln parkFrance generalRoad townBritish virgin islands generalUnited kingdomMark simonStimunity saIan waltersJames mellonLinda kozickOncomer saugatuckAllan shawCantor fitzgerald coDetails of the company

BioCardia : Termination of Material Agreement

bcda20230629 8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT .

United statesLincoln parkPeter altmanCompany current report on formSecurities exchangeCantor fitzgerald coBiocardia incLincoln park capital fundCompany controlled equity offering sales agreementSecurities exchange actSecurities actExchange actPurchase common stockMaterial definitivePurchase agreementCurrent report

Avalo Therapeutics : Termination of Material Agreement - Form 8-K

avtx-20230420 UNITED STATES . | April 21, 2023

United statesChristopher sullivanSecurities exchangeCommission file numberCapital marketsAvalo therapeutics incCantor fitzgerald coGrowth companyCompany current report on formExchange commission onSecurities exchange actZip codeTelephone numberIncluding area codeSecurities actExchange act

vimarsana © 2020. All Rights Reserved.